These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33567388)

  • 1. Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study.
    Jin Z; Chen L; Zhong B; Zhou H; Zhu H; Zhou H; Song J; Guo J; Zhu X; Ji J; Ni C; Teng G
    Transl Oncol; 2021 Apr; 14(4):101034. PubMed ID: 33567388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
    Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Zhao Y; Wang N; Wu J; Zhang Q; Lin T; Yao Y; Chen Z; Wang M; Sheng L; Liu J; Song Q; Wang F; An X; Guo Y; Li X; Wu T; Liu AL
    Front Oncol; 2021; 11():582788. PubMed ID: 33868988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.
    Yang Y; Fan W; Gu T; Yu L; Chen H; Lv Y; Liu H; Wang G; Zhang D
    Front Oncol; 2021; 11():756216. PubMed ID: 34692547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.
    Xi Z; Ye Y; Yang Y; He Y; Song Z; Ma Q; Zeng H; Shao G
    Abdom Radiol (NY); 2024 Jul; 49(7):2387-2400. PubMed ID: 39030402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Meng XP; Wang YC; Ju S; Lu CQ; Zhong BY; Ni CF; Zhang Q; Yu Q; Xu J; Ji J; Zhang XM; Tang TY; Yang G; Zhao Z
    Front Oncol; 2020; 10():1196. PubMed ID: 32850345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
    Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
    Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
    Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study.
    Liu Z; Luo C; Chen X; Feng Y; Feng J; Zhang R; Ouyang F; Li X; Tan Z; Deng L; Chen Y; Cai Z; Zhang X; Liu J; Liu W; Guo B; Hu Q
    Int J Surg; 2024 Feb; 110(2):1039-1051. PubMed ID: 37924497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model.
    Zhang X; He Z; Zhang Y; Kong J
    Front Pharmacol; 2024; 15():1315732. PubMed ID: 38344175
    [No Abstract]   [Full Text] [Related]  

  • 14. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
    Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
    Yang L; Gu D; Wei J; Yang C; Rao S; Wang W; Chen C; Ding Y; Tian J; Zeng M
    Liver Cancer; 2019 Oct; 8(5):373-386. PubMed ID: 31768346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    Kim J; Choi SJ; Lee SH; Lee HY; Park H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Chen M; Cao J; Hu J; Topatana W; Li S; Juengpanich S; Lin J; Tong C; Shen J; Zhang B; Wu J; Pocha C; Kudo M; Amedei A; Trevisani F; Sung PS; Zaydfudim VM; Kanda T; Cai X
    Liver Cancer; 2021 Feb; 10(1):38-51. PubMed ID: 33708638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Peng G; Cao X; Huang X; Zhou X
    Eur J Radiol Open; 2024 Jun; 12():100551. PubMed ID: 38347937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI.
    Zhang HD; Li XM; Zhang YH; Hu F; Tan L; Wang F; Jing Y; Guo DJ; Xu Y; Hu XL; Liu C; Wang J
    J Clin Transl Hepatol; 2023 Apr; 11(2):350-359. PubMed ID: 36643030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning.
    Peng J; Huang J; Huang G; Zhang J
    Front Oncol; 2021; 11():730282. PubMed ID: 34745952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.